CRISPR Therapeutics reached a significant milestone a couple of years ago: its first product approval. The company’s stock, ...

Gene editing has rapidly evolved into a transformative class of technologies that allow scientists to precisely insert, ...

Satyen K. Bordoloi My first memory of cancer is the younger brother of a classmate. Blood cancer, we whispered between ...

A dire wolf de-extinction debate, CRISPR-GPT for gene editing, and more topped the list of our most popular stories in ...

A miracle baby who was treated with a pioneering gene-therapy at CHOP has reached a major milestone as he took his first ...

The baby saved from a rare disease by a first-ever personalized gene fix has reached a big milestone, taking his first steps ahead of Christmas. KJ Muldoon is walking and getting ready to celebrate ...

Talk about a Christmas miracle!A medical breakthrough came just in time and changed one baby’s life — and gave his family a ...

The first infant to undergo gene-editing therapy has accomplished another first — his first steps. KJ Muldoon is walking and ...

Wondering if CRISPR Therapeutics is still a high risk biotech story or a quietly mispriced opportunity? This breakdown will help you decide whether the current share price makes sense for a long term ...

Precise tumor diagnosis and treatment require the support of abundant molecular information. However, conventional molecular ...

A 10-month-old baby who sparked nationwide headlines after receiving a first-of-its kind gene-editing treatment was released ...

The baby saved from a rare disease by a first-ever personalized gene fix has reached a big milestone, taking his first steps ...